Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05061095 · ClinicalTrials.gov registry record
Understanding What Matters Most to Patients: Establishing the Validity of a Best-Worst Scaling Survey
A clinical trial, sponsored by UNC Lineberger Comprehensive Cancer Center.
- Completed
- Registry status
- 51
- Enrollment target
NCT05061095 is a clinical trial that has completed, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 51 participants.
The verdict
NCT05061095 has completed, sponsored by UNC Lineberger Comprehensive Cancer Center.
- COMPLETED
- Registry status
- 51 participants
- Enrollment target
Study Summary
This study will evaluate the validity of using a survey to quantify patient preferences at the point-of-care and the potential effectiveness of the survey to improve goal-concordant care. The primary hypothesis is that by identifying the strength of patient preferences for outcomes with this survey clinicians will be able to improve goal-concordant care by aligning clinical recommendations with patients' preferences. This study will have 50 patients with newly diagnosed hematologic malignancy complete the survey throughout their disease course (up to 2 years) and conduct qualitative interviews with a subset (n = 20) of participants. The information obtained from these participants will be used to refine the survey. Interviews with oncologists and palliative care specialists (up to 10) will inform implementation.
Interventions
- OTHER Assessment Surveys
- OTHER Qualitative Interviews
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2022-03-21 |
| Est. Completion | 2023-09-26 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05061095
The ClinicalTrials.gov registry entry for NCT05061095 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UNC Lineberger Comprehensive Cancer Center, which has 366 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Assessment Surveys is the first listed.
NCT05061095 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05061095 about?
NCT05061095 is a clinical study titled "Understanding What Matters Most to Patients: Establishing the Validity of a Best-Worst Scaling Survey". This study will evaluate the validity of using a survey to quantify patient preferences at the point-of-care and the potential effectiveness of the survey to improve goal-concordant care. The primary hypothesis is that by identifying the strength of patient preferences for outcomes with this survey ...
What is the current status of trial NCT05061095?
This trial is currently completed. The enrollment target is 51 participants. The study started on 2022-03-21. Estimated completion is 2023-09-26.
What interventions are being tested in trial NCT05061095?
The interventions under investigation include: Assessment Surveys (OTHER), Qualitative Interviews (OTHER).
Who is sponsoring clinical trial NCT05061095?
This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.